Medical Grand Rounds - Adrenocortical Carcinoma: A Case Presentation
Presenters: Robert Terry, MD, 3rd Year, Family Medicine Resident, Family Medicine Residency; Patricia Maani-Fogelman, DNP, System Director, Palliative Medicine; and Julie Richards, DNP, Cancer Treatment Center
At the conclusion of this activity, participants should be able to:
- Discuss the diagnostic workup of adrenocortical carcinoma.
- Discuss the role of IGF in the pathophysiology of non-islet cell tumors.
- Identify treatment approaches to resistant hypoglycemia in malignant tumors.
- Discuss the chemotherapeutic implications in adrenocortical carcinoma.
- Identify 3 trigger criteria for early engagement and collaboration with Palliative Medicine to optimize cancer care delivery.
- Identify 3 key communication tools to initiate complex discussions when goals are not concordant with patients and their families/caregivers.
Date: Friday, March 12, 2021
Time: 12 p.m.
Location: Microsoft Teams - E-mail Trish.Stern@Guthrie.org to be included
This program is intended for: Physicians, Advanced Practice Providers, Fellows, Residents, Medical and Nursing Students, and other Ancillary Healthcare Professionals.
Accreditation Statement
“The Guthrie Clinic is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.”
Designation Statement
“The Guthrie Clinic designates this live activity for a maximum of (1.0) AMA PRA Category I Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”
Disclosure/Conflict of Interest Statement
“Faculty and all others who have the ability to control the content of continuing medical education activities sponsored by The Guthrie Clinic are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).” The presenter and all other persons planning the content of this program have indicated they DO NOT have any significant commercial interests that may bias the presentation.